49
Participants
Start Date
August 21, 2020
Primary Completion Date
August 5, 2026
Study Completion Date
August 5, 2026
Biopsy
Undergo biopsy
Cisplatin
Given via PIPAC
Doxorubicin
Given via PIPAC
Fluorouracil
Given IV
Intraperitoneal Chemotherapy
Undergo PIPAC
Irinotecan
Given IV
Leucovorin
Given IV
Mitomycin
Given via PIPAC
Oxaliplatin
Given via PIPAC
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
RECRUITING
Northwell Health Cancer Institute at Huntington, Greenlawn
RECRUITING
City of Hope Medical Center, Duarte
RECRUITING
Mayo Clinic in Florida, Jacksonville
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER